ELOX
Eloxx Pharmaceuticals, Inc.
13.90$
+1.1%
vs. previous close
Closing price · As of: Oct 12, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q1 23 | Q2 23 | Q3 23 | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -38.73 | -50.58 | -48.19 | -49.49 | -35.27 | -34.60 | -10.27 | -13.81 | 3.48 | – | -1.24 | -0.71 | |
| 1.42 | 1.03 | 1.01 | 0.66 | 0.96 | 0.94 | 0.92 | 0.75 | – | – | – | – | |
| – | – | – | – | – | – | – | – | 0.06 | – | 0.01 | 0.01 | |
| 1.25 | 1.20 | 3.12 | -0.17 | -2.18 | -9.68 | 7.11 | -1.00 | 7.61 | – | -0.39 | -0.02 | |
| 0.35 | 0.10 | 0.06 | 0.04 | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 | – | 0.00 | 0.00 | |
| -0.35 | -0.10 | -0.06 | -0.04 | -0.24 | 0.06 | 0.07 | 0.93 | – | – | – | – | |
| – | – | – | – | – | – | – | – | -2.50 | – | 0.00 | 0.00 | |
| 17.12 | -0.81 | 35.54 | – | 7.62 | -38.08 | 7.10 | 14.69 | -2.50 | – | 1.60 | 8.89 | |
| -21.96 | -51.50 | -12.70 | -49.53 | -27.90 | -72.63 | -3.10 | 1.81 | 0.98 | – | 0.31 | 8.19 | |
| -39.08 | -50.68 | -48.25 | -49.53 | -35.51 | -34.60 | -10.27 | -13.81 | 3.48 | – | -1.24 | -0.71 |
Data as of: October 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.